Document is current
Any future updates will be listed below
-
Authors
Pearson, Sam M.
Whittam, Beverley
Kulavarasalingam, Kavita
Mitchell-Gears, Amelia
James, Cathyrn
Ajjan, Ramzi A. https://orcid.org/0000-0002-1636-3725
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04422145 at ClinicalTrials.govDocuments that mention this clinical trial
Reduction in cardiovascular mortality following severe hypoglycemia in individuals with type 2 diabetes: the role of a pragmatic and structured intervention
https://doi.org/10.1186/s12933-020-01204-3
-
Funding
Funding for this research was provided by:
LifeScan (RG.MOVA.483906)
National Institute for Health Research
- License Information
-
More Information
Article History
Received: 21 August 2020
Accepted: 24 December 2020
First Online: 12 January 2021
Ethics approval and consent to participate
: The study was approved by the local ethical Committee, Leeds and Bradford with IRAS number 100244. Individuals were enrolled after written informed consent had been obtained.
: No patient identifiable information is included in this manuscript.
: R.A.A received Institutional Research Grants from Abbott, Bayer, Eli Lilly, LifeScan, NovoNordisk, Roche, Takeda as well as honoraria/education support/consultancy from Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck Sharp & Dohme, NovoNordisk and Takeda. All other authors declare that they have no competing interests.
